ANGEL SZKUTAK: Open Payments
NPI 1407129109 · DERBY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,728 in 84 payments from 16 companies in 2025. Trend: 2023 $2,565 · 2024 $2,656 · 2025 $1,728
Food & beverage: $1,728
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $316 |
| Lilly USA, LLC | 14 | $287 |
| GlaxoSmithKline, LLC. | 11 | $214 |
| PFIZER INC. | 8 | $180 |
| Novo Nordisk Inc | 8 | $148 |
| ABBVIE INC. | 7 | $133 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $91 |
| Exact Sciences Corporation | 3 | $71 |
| Amgen Inc. | 3 | $62 |
| Boston Scientific Corporation | 2 | $50 |
Products named: FARXIGA, TRELEGY ELLIPTA, JARDIANCE, NURTEC ODT, MOUNJARO, UBRELVY, OTEZLA, WATCHMAN FLX.
Industry payments across NY — which companies pay providers there.
